Bristol Myers gets USFDA approval for First LAG-3-Blocking Antibody Combination, Opduala MD Bureau20 March 2022 2:30 PM ISTThe trial met its primary endpoint, progression-free survival, and Opdualag more than doubled the median PFS when compared to nivolumab monotherapy,...
Bristol Myers Squibb Nivolumab marketing approval to be revoked for hepatocellular carcinoma: CDSCO panel Dr. Divya Colin14 March 2022 6:30 PM ISTNew Delhi: In a major setback for Bristol Myers Squibb, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
USFDA accepts Bristol Myers Squibb's Application for Opdivo MD Bureau2 March 2022 12:10 PM ISTThe FDA granted the application Priority Review status and assigned a Prescription Drug User Fee Act (PDUFA) goal date of July 13, 2022.
USFDA accepts Bristol Myers Orencia application for priority review Ruchika Sharma24 Aug 2021 12:00 PM ISTPrinceton: Bristol Myers Squibb has recently announced that the U.S. Food and Drug Administration (USFDA) has accepted the company's...
Sun Pharma settles patent dispute with Celgene over generic Revlimid Ruchika Sharma22 Jun 2021 12:24 PM ISTMumbai: Sun Pharmaceutical Industries Limited along with one of its wholly owned subsidiaries today announced that they have reached an agreement...
Bristol-Myers, Eisai in up to USD 3.1 billion deal to develop cancer drug candidate Medical Dialogues Team19 Jun 2021 11:00 AM ISTNew Delhi: Bristol-Myers Squibb Co and Eisai Co said on Thursday they had entered into an agreement worth up to USD 3.10 billion to jointly develop...
Bristol-Myers Squibb gets USFDA nod to multiple myeloma therapy Ruchika Sharma29 March 2021 10:15 AM ISTNew Delhi: The U.S. Food and Drug Administration has approved Bristol-Myers Squibb Co and bluebird bio Inc's multiple myeloma therapy, ide-cel,...
Bristol Myers Squibb submission for Mavacamten to treat Obstructive Hypertrophic Cardiomyopathy accepted by USFDA Ruchika Sharma21 March 2021 10:45 AM ISTPrinceton: Pharma major, Bristol Myers Squibb, has recently announced that the U.S. Food and Drug Administration (USFDA) has accepted its New Drug...
Sanofi, Bristol Myers directed to pay USD 834 million over Plavix warning label Ruchika Sharma18 Feb 2021 12:44 PM ISTOchiai, who presided over a four week, non jury trial conducted entirely over Zoom due to the COVID-19 pandemic, ordered Bristol Myers and Sanofi to...
Bristol Myers Squibb gets EMA nod for Zeposia to treat ulcerative colitis Ruchika Sharma1 Jan 2021 10:00 AM ISTPrinceton: Bristol Myers Squibb has recently announced that the European Medicines Agency (EMA) has validated its Marketing Authorization...
Cipla Settles Patent Litigation over REVLIMID Capsules with Celgene, Bristol Myers in US Ruchika Sharma12 Dec 2020 4:36 PM ISTAs part of the settlement, the Parties will file Consent Judgments with the United States District Court for the District of New Jersey that enjoin...
USFDA delays decision on Bristol Myers cancer therapy due to COVID-19 travel curbs Ruchika Sharma18 Nov 2020 9:00 AM ISTNew Delhi: Bristol Myers Squibb said on Monday the U.S. health regulator has deferred a decision on an experimental blood cancer therapy that it...
